Category: biotech

.AstraZeneca has made use of artificial intelligence to create an unique biomarker for its own Daiichi Sankyo-partnered datopotamab deruxtecan (Dato-DXd), hoping to vary the antibody-drug

.AN2 Rehabs is actually rethinking its own company in feedback to lackluster midphase data, swearing to lay off half its workers and stop a period

.ALX Oncology’s stage 2 gastric cancer cells response fee has actually weakened. After observing its CD47 blocker conveniently hammered control over the very first half

.After more than twenty years of deal with neurodegenerative diseases, Swiss biotech air conditioner Immune insurance claims it could have a game changer on its